Are Your Granted Patents in Danger of a Post-Grant Double Patenting Challenge?
From Academia to the Marketplace: The Ins and Outs of University Spinout Licenses with Dan O’Korn
Nonpublication Requests For Patent Applications: Disadvantages
Podcast: Blockchain Intellectual Property Considerations for Innovators and Investors
Enforcement Challenges For Biotech Patents
Is the Patent Litigation Boom Coming to an End?
Patent Series: Protecting inventions
A federal district court recently dismissed a lawsuit against AbbVie and biosimilar manufacturers of adalimumab involving a novel antitrust claim against the Humira patent estate. Attorneys with Haug Partners LLP take an...more
To date, Amgen has been the reference product sponsor for many biosimilar applications. Correspondingly, Amgen has been the Plaintiff in many of the litigations that have been based on the provisions of the Biosimilar Price...more